1 / 7

HER-2 Positive Breast Cancer Market in the US 2015-2019

Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated carcinoma. Breast cancer is the second most common form of cancer in women. HER-2 is a protein that affects the growth of malignant cells and is usually found on the surface of normal breast cells. Sometimes, a large number of HER-2 receptors are found on the surface of breast cancer cells. These HER-2 receptors are responsible for stimulating the growth and division of malignant cancerous cells. This condition is therefore known as HER-2 positive breast cancer. HER-2 positive breast cancers have a tendency to spread and metastasize more rapidly than HER-2 negative breast cancers. HER-2 positive breast cancer is more prevalent in females than males. In 2012, GLOBOCAN reported that breast cancer accounted for 11.9 percent of the total number of cancer cases and led to 522,000 deaths worldwide. HER-2 positive breast cancer accounts for almost 25 percent of all types of breast cancer. Analysts forecast the HER-2 Positive Breast Cancer market in US to grow at a CAGR of 12.65 percent over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/her-2-positive-breast-cancer-in-the-us-2015-2019-market

jimmies026
Download Presentation

HER-2 Positive Breast Cancer Market in the US 2015-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 HER-2 Positive Breast Cancer Market in the US 2015-2019

  2. Description Report Overview About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated carcinoma. Breast cancer is the second most common form of cancer in women. HER-2 is a protein that affects the growth of malignant cells and is usually found on the surface of normal breast cells. Sometimes, a large number of HER-2 receptors are found on the surface of breast cancer cells. These HER-2 receptors are responsible for stimulating the growth and division of malignant cancerous cells. This condition is therefore known as HER-2 positive breast cancer. HER-2 positive breast cancers have a tendency to spread and metastasize more rapidly than HER-2 negative breast cancers. Analysts forecast the HER-2 Positive Breast Cancer market in US to grow at a CAGR of 12.65 percent over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/her-2-positive-breast-cancer-in-the-us-2015-2019-market @Bigmarketresearch

  3. Description Report Overview This report covers the present scenario and the growth prospects of the HER-2 Positive Breast Cancer market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of targeted therapeutics and chemotherapeutics used in the management of HER-2 positive breast cancer patients. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the HER-2 Positive Breast Cancer market in the US. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. HER-2 Positive Breast Cancer Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the HER-2 Positive Breast Cancer market in the US and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. @Bigmarketresearch

  4. Description Report Overview Key Vendors • Celgene • F. Hoffmann-La Roche • GlaxoSmithKline • Novartis • Sanofi Other Prominent Vendors • Bristol-Myers Squibb • DARA BioSciences • Eisai • Hospira • Pfizer • ProStrakan • Sun Pharmaceutical Industries • Teva Pharmaceutical @Bigmarketresearch

  5. Description Report Overview Market Driver • Increase in Population of Breast Cancer Patients • For a full, detailed list, view our report Market Challenge • Poor Diagnosis and Screening • For a full, detailed list, view our report Market Trend • Increase in Awareness • For a full, detailed list, view our report Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/183633 @Bigmarketresearch

  6. Table Of Contents Table Of Content • 01. Executive Summary • 02. List of Abbreviations • 03. Scope of the Report • 04. Market Research Methodology • 05. Introduction • 06. Disease Overview • 07. Market Landscape • 08. Market Segmentation by Type of Therapy • 09.9 Market Segmentation by Molecule Type • 10 Market Segmentation by Route of Administration • 11 Buying Criteria • 12 Market Growth Drivers • 13 Drivers and their Impact • 14 Market Challenges • 15 Impact of Drivers and Challenges • 16 Market Trends • 17 Trends and their Impact • 18 Vendor Landscape • 19 Key Vendor Analysis • 20 Other Reports in this Series @Bigmarketresearch

  7. Get Full Information At: http://www.bigmarketresearch.com/her-2-positive-breast-cancer-in-the-us-2015-2019-market

More Related